Concepedia

Kevan Hosseini

KH

Statistics

Publications

4

Citations

174

H-Index

4

Active since

2017

Affiliations

Saarland University(Current)

Otto-von-Guericke-Universität Magdeburg

Medical University of Graz

Max Planck Institute for Informatics

Goethe University Frankfurt

Kevan Hosseini is an author at Saarland University specializing in molecular oncology, oncology, and medicine.

Publications per year

2017–2019

4

Publications

4

The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma

Christina S. Schultheiss, Stephan Laggai, Beate Czepukojc et al. · Cell Stress · 2017 · 69 citations · Full text

, , +17

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer

Sonja M. Kessler, Eva Lederer, Stephan Laggai et al. · Oncotarget · 2017 · 41 citations · Full text

, , +15

Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival

Sonja M. Kessler, Kevan Hosseini, Usama Khamis Hussein et al. · Cellular Physiology and Biochemistry · 2019 · 37 citations · Full text

, , +15

The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma

Tarek Kröhler, Sonja M. Kessler, Kevan Hosseini et al. · Cancers · 2019 · 27 citations · Full text

, , +17

1–4 of 4